MoleculeMind announced that it has received CNY 100 million in funding from Lenovo Capital and Incubator Group, Sequoia China Investment Management LLP, Cathay Biotech Inc.

MoleculeMind announced that it has received over CNY 100 million led by Cathay Biotech Inc. on February 20, 2023. The transaction included participation from new investor Lenovo Capital and Incubator Group and returning investor Sequoia China Investment Management LLP.